Terns Pharmaceuticals, Inc.
TERNDelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831363
Terns Pharmaceuticals, Inc. was delisted in 2026; its insiders filed their last Form 4 on May 5, 2026; 317 institutions reported holding it in 13F filings for Q1 2026, worth $6.56B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q2 2022
Institutional positions in Terns Pharmaceuticals, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 42
- 0 vs. Q1 2022
- Shares held
- 14.7M
- −2.09M (−12.4%) vs. Q1 2022
- Total value
- $36.6M
- −$13.3M (−26.7%) vs. Q1 2022
- New holders
- 13
- 11 more added
- Sold out
- 13
- 13 more reduced
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TERN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 2 | $659.7K |
| Q1 2026 | 317 | $6.56B |
| Q4 2025 | 248 | $4.95B |
| Q3 2025 | 141 | $670.8M |
| Q2 2025 | 130 | $310.7M |
| Q1 2025 | 139 | $229.6M |
| Q4 2024 | 157 | $477.2M |
| Q3 2024 | 156 | $663.6M |
| Q2 2024 | 126 | $447.7M |
| Q1 2024 | 112 | $425.3M |
| Q4 2023 | 103 | $425.3M |
| Q3 2023 | 93 | $310.4M |
| Q2 2023 | 103 | $505.1M |
| Q1 2023 | 79 | $720.7M |
| Q4 2022 | 65 | $506.2M |
| Q3 2022 | 45 | $178.1M |
| Q2 2022 | 42 | $36.6M |
| Q1 2022 | 44 | $50.0M |
| Q4 2021 | 37 | $116.7M |
| Q3 2021 | 34 | $174.3M |
| Q2 2021 | 36 | $203.8M |
| Q1 2021 | 42 | $393.7M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Terns Pharmaceuticals, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 3,791,204 | $9.40M | 0.17% | 00.0% | Unchanged |
| Vivo Capital, LLC | 2,675,133 | $6.63M | 0.67% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 1,261,435 | $3.13M | 0.08% | +1,261,435 | New |
| Suvretta Capital Management, LLC | 1,238,800 | $3.07M | 0.12% | 00.0% | Unchanged |
| Antara Capital LP | 874,600 | $2.17M | 0.22% | −200,234−18.6% | Reduced |
| Decheng Capital Management III (Cayman), LLC | 714,285 | $1.77M | 0.67% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 700,000 | $1.74M | 0.72% | +700,000 | New |
| Point72 Asset Management, L.P. | 500,000 | $1.24M | 0.01% | +377,427+307.9% | Added |
| Affinity Asset Advisors, LLC | 401,268 | $995.0K | 0.54% | +401,268 | New |
| Vanguard Group Inc | 367,529 | $912.0K | 0.00% | −65,490−15.1% | Reduced |
| Armistice Capital, LLC | 323,016 | $801.0K | 0.01% | +323,016 | New |
| Samsara BioCapital, LLC | 289,068 | $717.0K | 0.19% | 00.0% | Unchanged |
| Millennium Management LLC | 277,688 | $689.0K | 0.00% | +189,178+213.7% | Added |
| Driehaus Capital Management LLC | 210,074 | $521.0K | 0.01% | +174,974+498.5% | Added |
| Renaissance Technologies LLC | 184,416 | $457.0K | 0.00% | +116,616+172.0% | Added |
| BlackRock Inc. | 149,528 | $371.0K | 0.00% | −587,413−79.7% | Reduced |
| Boothbay Fund Management, LLC | 106,712 | $265.0K | 0.01% | +106,712 | New |
| FMR LLC | 101,675 | $252.0K | 0.00% | −2,219,783−95.6% | Reduced |
| Caas Capital Management LP | 97,512 | $242.0K | 0.03% | +11,661+13.6% | Added |
| Geode Capital Management, LLC | 79,324 | $196.0K | 0.00% | −99,987−55.8% | Reduced |
| Ergoteles LLC | 63,454 | $157.0K | 0.00% | +63,454 | New |
| Marquette Asset Management, LLC | 57,876 | $144.0K | 0.04% | +36,074+165.5% | Added |
| PEAK6 Investments LLC | 14,097 | $123.3K | 0.00% | +14,097 | New |
| Bridgeway Capital Management, LLC | 45,500 | $113.0K | 0.00% | −17,200−27.4% | Reduced |
| Citadel Advisors LLC | 38,810 | $96.0K | 0.00% | +38,810 | New |
| Bailard, Inc. | 20,300 | $50.0K | 0.00% | +20,300 | New |
| State Street Corp | 19,837 | $49.0K | 0.00% | −143,400−87.8% | Reduced |
| Morgan Stanley | 18,671 | $46.0K | 0.00% | +10,180+119.9% | Added |
| Bank of America Corp | 18,108 | $45.0K | 0.00% | +10,884+150.7% | Added |
| Goldman Sachs Group Inc | 16,588 | $41.0K | 0.00% | +161+1.0% | Added |
| Northern Trust Corp | 14,373 | $36.0K | 0.00% | −90,449−86.3% | Reduced |
| Barclays PLC | 13,125 | $33.0K | 0.00% | −2,227−14.5% | Reduced |
| Acadian Asset Management LLC | 12,627 | $31.0K | 0.00% | +12,627 | New |
| Qube Research & Technologies Ltd | 11,408 | $28.0K | 0.00% | +11,408 | New |
| Tower Research Capital LLC (TRC) | 10,480 | $26.0K | 0.00% | +6,924+194.7% | Added |
| Cubist Systematic Strategies, LLC | 2,428 | $6.00K | 0.00% | +1,228+102.3% | Added |
| JPMorgan Chase & Co | 963 | $2.00K | 0.00% | −8,404−89.7% | Reduced |
| Citigroup Inc | 519 | $1.00K | 0.00% | −548−51.4% | Reduced |
| New York State Common Retirement Fund | 118 | $0 | 0.00% | −5,800−98.0% | Reduced |
| Wells Fargo & Company | 52 | $0 | 0.00% | −561−91.5% | Reduced |
| Credit Suisse AG | 7 | $0 | 0.00% | +7 | New |
| Capital Advisors, Ltd. LLC | 102 | $0 | 0.00% | +102 | New |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −2,345,959−100.0% | Sold out |
| Cowen and Company, LLC | 0 | $0 | 0.00% | −85,000−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −38,059−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −28,746−100.0% | Sold out |
| Nuveen Asset Management, LLC | 0 | $0 | 0.00% | −14,237−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −8,033−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −6,811−100.0% | Sold out |
| California State Teachers Retirement System | 0 | $0 | 0.00% | −5,987−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −2,079−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −1,454−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −843−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −708−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −71−100.0% | Sold out |
| Parametric Portfolio Associates LLC | – | – | – | – | Not filed |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |